With 2nd cohort they announced the 28 day safety milestone on 17th Dec 2021 and then some efficacy data on 7th Feb 2022.
So hopefully we may hear something with regards to efficacy before the end of the quarter.
- Forums
- ASX - By Stock
- Ann: Follow up period completed for 3rd cohort in CHM 1101 trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

With 2nd cohort they announced the 28 day safety milestone on...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 243067 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 14771167 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 243067 | 0.004 |
39 | 25597272 | 0.003 |
14 | 13250506 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 14771167 | 22 |
0.006 | 13177711 | 13 |
0.007 | 3200000 | 3 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |